San Francisco, US [January 08, 2018] – AMRA, the international leader in body composition analysis, will be presenting today at Biotech Showcase™. The showcase takes place during one of the industry’s largest annual healthcare investor conferences; the J.P. Morgan Annual Healthcare Conference.
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives.
Jeremy Edwards, Senior Vice President, Global Sales for AMRA, will be presenting corporate overview at a subset of the event known as the Digital Medicine and Medtech Showcase. The details are as follows:
Date: Wednesday, January 10, 2018 at 1pm
Room: Cyril Magnin II and III, Level 4
Venue: Parc 55, 55 Cyril Magnin St, San Francisco, CA 94102 (United States)
AMRA is the international leader in body composition analysis and the first in the world to transform images from a rapid, 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements. AMRA’s cloud-based analysis service offers precise, automated insights that have far-reaching implications for the pharmaceutical industry, academic R&D and, soon, clinical practice.
Mr. Edwards said, “I am excited to have the opportunity to take part in the BioTech Showcase this year. Traditional measurements of body composition rely on indirect physical measurements such as waist circumference, and AMRA is well-positioned to redefine the medical world’s understanding of body composition and allow more personalized treatments for those at risk of poor metabolic health outcomes.”
Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that AMRA is presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”
AMRA is the first in the world to transform images from a rapid, 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements. AMRA’s cloud-based analysis service offers precise, automated insights that have far-reaching implications for the pharmaceutical industry, academic R&D and, soon, clinical practice. AMRA was founded in 2010 as a spin-off of the Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering (IMT) and the Department of Medicine and Health (IMH) at Linköping University, Sweden. For more information, visit www.amra.se.
Advanced MR Analytics AB
SVP Business Development
Additional links and information: